Kathryn Ries Tringale
@kathryntringale
Radiation oncologist at UCSD specializing in CNS and Heme malignancies
ID: 1368198884556746756
06-03-2021 13:56:53
44 Tweet
93 Takipçi
50 Takip Edilen
New study on #AYAs & #financialtoxicity! 🚨💰(Memorial Sloan Kettering Cancer Center Fumiko Ladd Chino, MD, FASCO) #lymsm #ayacsm ➡️redcap.mskcc.org/surveys/?s=J73… (1/3)
🙏Please share with your networks, Escape Stupid Cancer Elephants and Tea Triage Cancer Cancer and Careers 13thirty Cancer Connect Teen Cancer America b-present Cactus Cancer Society (Lacuna Loft) Adolescent & Young Adult Cancer Alliance ➡️ redcap.mskcc.org/surveys/?s=J73… (3/3)
New research in Nature Communications from The Pike Lab, Niki Schultz & team describe the genomics and clinical outcomes of a large set of patients with #NSCLC brain metastasis. The findings could help guide future treatment decisions. nature.com/articles/s4146…
Genomic analysis of 233 non-small cell #LungCancer patients with #BrainMetastasis reveals distinct mutational patterns #CancerResearch by @Dr_Luke_Pike The Pike Lab Henry Walch Kathryn Ries Tringale Anna Skakodub Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center Cancer at Nature Portfolio nature.com/articles/s4146…
New from recent #radonc grad Dr Kathryn Ries Tringale: Over HALF of spine MRIs in pts with cancer ordered for back pain had cancer related findings & most findings (77-89%) were new/progressive. Total spine MRI increased odds of capturing new disease. 🩻journals.lww.com/spinejournal/a…
New in JTO & JTO CRR from Dr Brandon Imber: Intracranial response to #osimertinib is excellent for pts with #EGFR-mutant #NSCLC #lcsm with de novo, previously untx brain metastases. Low local failure rates support upfront osimertinib alone in selected pts. sciencedirect.com/science/articl…
This study led by Dr Suzanne Wolden Memorial Sloan Kettering Cancer Center is the largest, most recent analysis of the efficacy & safety of #IORT in #pedcsm pts with relapsed or refractory #neuroblastoma. It shows IORT is an effective & safe technique to achieve local control. sciencedirect.com/science/articl…
New by PGY2 Dr Nikhil Mankuzhy, MD with Dr Suzanne Wolden: Re-irradiation with hypofractionation for locally recurrent diffuse intrinsic pontine glioma #DIPG achieved survival duration comparable to published outcomes & effectively palliated symptoms. #pedcsm onlinelibrary.wiley.com/doi/10.1002/pb…
☢️🧠Neurosurgery Publications: This Memorial Sloan Kettering Cancer Center retrospective review of 102 consecutive pts treated with spine reirradiation. In pts with extensive disease involvement, re #SBRT of spine metastases with 40 Gy in 5 fractions seems to be safe & effective. journals.lww.com/neurosurgery/f…
New at #AACR24: Drs Jonathan Yang & Brandon Imber present research on a new tx for GBM --study drug AZD1390 & #radiotherapy. Dr Imber: “I think this is a promising and novel therapeutic combination for one of the most difficult-to-treat cancers.” 🧠☢️ mskcc.org/news/aacr-2024…
I'm so pleased to share that work led by Kathryn Ries Tringale on the "Prognostic Implications of SCLC Transcriptional Subtyping for CNS Mets" is online at JCO Precision Oncology (ascopubs.org/doi/full/10.12…)! Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center
In Journal of the @NCCN - we analyzed #medicare data to estimate usage patterns for hypofractionated #radiotherapy for elderly pts with 🧠 tumors and found interesting differences in use by site of care. Great work with Kathryn Ries Tringale Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center doi.org/10.6004/jnccn.…
New by Dr Kathryn Ries Tringale The Pike Lab: Small cell #lungcancer often metastasizes to the brain & has poor prognosis. This analysis of #SCLC #lcsm transcriptional factor subtypes finds differential CNS-specific outcomes & may help guide personalized care ascopubs.org/doi/full/10.12…
Survey on survivorship in Hodgkin Lymphoma 💚 redcap.mskcc.org/surveys/?s=J73… Please share with your networks! Hodgkin's International ILROG Team Escape Stupid Cancer Elephants and Tea Triage Cancer Cancer and Careers Memorial Sloan Kettering Radiation Oncology ASCO Adolescent & Young Adult Cancer Alliance 13thirty Cancer Connect Teen Cancer America ASTRO
Active CNS 🧠 disease is a major challenge for #lymphoma pts planned for CAR T cells. CNS bridging #radiotherapy can rapidly cytoreduce these high risk pts. The Memorial Sloan Kettering Cancer Center initial experience out in Blood Advances Memorial Sloan Kettering Radiation Oncology ashpublications.org/bloodadvances/…